These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 24206968)

  • 1. Exclusive low-molecular-weight heparin as bridging anticoagulant after mechanical valve replacement.
    Kindo M; Gerelli S; Hoang Minh T; Zhang M; Meyer N; Announe T; Bentz J; Mansour Z; Mommerot A; Petit-Eisenmann H; Kremer H; Collange O; Pottecher J; Cristinar M; Thiranos JC; Billaud P; Mazzucotelli JP
    Ann Thorac Surg; 2014 Mar; 97(3):789-95. PubMed ID: 24206968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight heparin as a bridging anticoagulant early after mechanical heart valve replacement.
    Meurin P; Tabet JY; Weber H; Renaud N; Ben Driss A
    Circulation; 2006 Jan; 113(4):564-9. PubMed ID: 16449734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of different bridging anticoagulation therapies used after mechanical heart valve replacement in Chinese patients - a prospective cohort study.
    Li BX; Liu SD; Qi L; Sun S; Sun W; Li YM; Song B; Wu XA
    J Cardiothorac Surg; 2020 Feb; 15(1):40. PubMed ID: 32093747
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Half-dose enoxaparin vs. full-dose enoxaparin for postoperative bridging therapy in patients after cardiac surgery: which dose regimen should be preferred?
    Weiss A; Brose S; Ploetze K; Matschke K
    Clin Hemorheol Microcirc; 2013 Jan; 54(3):249-58. PubMed ID: 23648452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison on efficacy and safety of different bridging anticoagulation therapies in patients undergoing mechanical heart valve replacement surgery].
    Liu SD; Qi L; Li BX; Li X; Fang T; Song B
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Feb; 48(2):130-135. PubMed ID: 32135613
    [No Abstract]   [Full Text] [Related]  

  • 6. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
    Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
    J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periprocedural bridging therapy with low-molecular-weight heparin in chronically anticoagulated patients with prosthetic mechanical heart valves: experience in 116 patients from the prospective BRAVE registry.
    Hammerstingl C; Tripp C; Schmidt H; von der Recke G; Omran H
    J Heart Valve Dis; 2007 May; 16(3):285-92. PubMed ID: 17578050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk factors of early thromboembolic events after mechanical heart valve replacement in patients treated with intravenous unfractionated heparin.
    Allou N; Piednoir P; Berroëta C; Provenchère S; Ibrahim H; Baron G; Montravers P; Iung B; Philip I; Ajzenberg N
    Heart; 2009 Oct; 95(20):1694-700. PubMed ID: 19482850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the effectiveness and safety of low-molecular weight heparin versus unfractionated heparin anticoagulation after heart valve surgery.
    Bucci C; Geerts WH; Sinclair A; Fremes SE
    Am J Cardiol; 2011 Feb; 107(4):591-4. PubMed ID: 21184996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of safety of subcutaneous enoxaparin as outpatient anticoagulation bridging therapy in patients with a mechanical heart valve versus patients with nonvalvular atrial fibrillation.
    Bui HT; Krisnaswami A; Le CU; Chan J; Shenoy BN
    Am J Cardiol; 2009 Nov; 104(10):1429-33. PubMed ID: 19892063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-molecular-weight heparin as bridging anticoagulation during interruption of warfarin: assessment of a standardized periprocedural anticoagulation regimen.
    Douketis JD; Johnson JA; Turpie AG
    Arch Intern Med; 2004 Jun; 164(12):1319-26. PubMed ID: 15226166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The HAS-BLED score predicts bleedings during bridging of chronic oral anticoagulation. Results from the national multicentre BNK Online bRiDging REgistRy (BORDER).
    Omran H; Bauersachs R; Rübenacker S; Goss F; Hammerstingl C
    Thromb Haemost; 2012 Jul; 108(1):65-73. PubMed ID: 22534746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful use of fondaparinux for bridging early after aortic and mitral mechanical heart valve replacement.
    Perissinotti AJ; Dotson B; Baciewicz FA; Tennenberg SD
    Ann Pharmacother; 2012 Mar; 46(3):e9. PubMed ID: 22353236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticoagulant management of pregnant women with mechanical heart valve replacement during perioperative period.
    Bian C; Qi X; Li L; Zhao J; Liu X
    Arch Gynecol Obstet; 2016 Jan; 293(1):69-74. PubMed ID: 26048261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol.
    Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A
    J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic doses of low-molecular weight heparin as periprocedural bridging therapy in mechanical heart valve patients.
    Hjellström L; Labaf A
    Thromb Res; 2018 Mar; 163():180-184. PubMed ID: 28965992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative bridging therapy with unfractionated heparin or low-molecular-weight heparin in patients with mechanical prosthetic heart valves on long-term oral anticoagulants (from the REGIMEN Registry).
    Spyropoulos AC; Turpie AG; Dunn AS; Kaatz S; Douketis J; Jacobson A; Petersen H;
    Am J Cardiol; 2008 Oct; 102(7):883-9. PubMed ID: 18805116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The risk of bleeding associated with low molecular weight heparin in patients with renal failure].
    Lai S; Barbano B; Cianci R; Gigante A; Di Donato D; Asllanaj B; Dimko M; Mariotti A; Morabito S; Pugliese F
    G Ital Nefrol; 2010; 27(6):649-54. PubMed ID: 21132647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.
    Dentali F; Pignatelli P; Malato A; Poli D; Di Minno MN; Di Gennaro L; Rancan E; Pastori D; Grifoni E; Squizzato A; Siragusa S; Di Minno G; Ageno W
    Am J Hematol; 2012 Apr; 87(4):384-7. PubMed ID: 22367852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.